铁木制药

最新新闻

• 评级变动
  Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1.1
  \u5e02\u573a\u8d44\u8baf · 2025/4/29
• Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $5
  \u5e02\u573a\u8d44\u8baf · 2026/5/6
• 评级变动
  Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating
  \u5e02\u573a\u8d44\u8baf · 2025/11/10
• 评级变动
  Citizens JMP Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating, Raises Target Price to $10
  \u5e02\u573a\u8d44\u8baf · 2026/2/26
• 评级变动
  Craig-Hallum Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Announces Target Price $1
  \u5e02\u573a\u8d44\u8baf · 2025/4/17
• Ironwood Pharmaceuticals(IRWD.US) Director Sells US$20.53 Million in Common Stock
  \u5e02\u573a\u8d44\u8baf · 2026/3/18
• 评级变动
  Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1
  \u5e02\u573a\u8d44\u8baf · 2025/5/1
• Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/16
• 评级变动
  Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Raises Target Price to $3
  \u5e02\u573a\u8d44\u8baf · 2025/11/12
• 评级变动
  Leerink Partners Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Maintains Target Price $1
  \u5e02\u573a\u8d44\u8baf · 2025/4/16
• 评级变动
  Citizens JMP Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating, Announces Target Price $8
  \u5e02\u573a\u8d44\u8baf · 2026/1/5
• 评级变动
  Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2025/4/26
• OneMedNet Collaborates With Inka Health To Provide Access To U.S. Real‐World Oncology Data Via IRWD Platform Powered By Palantir Foundry
  Benzinga · 2026/4/1
• 评级变动
  Jefferies Downgrades Ironwood Pharmaceuticals(IRWD.US) to Hold Rating, Cuts Target Price to $0.7
  \u5e02\u573a\u8d44\u8baf · 2025/4/16
• 评级变动
  Wells Fargo Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Raises Target Price to $5
  \u5e02\u573a\u8d44\u8baf · 2026/1/5
• 评级变动
  Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Announces Target Price $3.8
  \u5e02\u573a\u8d44\u8baf · 2025/11/26
• Analysts' Top Healthcare Picks: Ironwood Pharma (IRWD), Sionna Therapeutics, Inc. (SION)
  TipRanks · 2026/5/14
• 评级变动
  Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Hold Rating, Announces Target Price $1.7
  \u5e02\u573a\u8d44\u8baf · 2025/10/29
• 评级变动
  Craig-Hallum Upgrades Ironwood Pharmaceuticals(IRWD.US) to Buy Rating, Raises Target Price to $5.7
  \u5e02\u573a\u8d44\u8baf · 2026/1/5
• 评级变动
  A Quick Look at Today's Ratings for Ironwood Pharmaceuticals(IRWD.US), With a Forecast Between $1 to $1
  \u5e02\u573a\u8d44\u8baf · 2025/4/15

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。